367 related articles for article (PubMed ID: 17523181)
21. The acute and chronic administration of the 5-HT(2B/2C) receptor antagonist SB-200646A significantly alters the activity of spontaneously active midbrain dopamine neurons in the rat: An in vivo extracellular single cell study.
Blackburn TP; Suzuki K; Ashby CR
Synapse; 2006 Jun; 59(8):502-12. PubMed ID: 16565966
[TBL] [Abstract][Full Text] [Related]
22. Effects of dizocilpine (MK-801) on rat midbrain dopamine cell activity: differential actions on firing pattern related to anatomical localization.
Murase S; Mathé JM; Grenhoff J; Svensson TH
J Neural Transm Gen Sect; 1993; 91(1):13-25. PubMed ID: 8452684
[TBL] [Abstract][Full Text] [Related]
23. Involvement of N-methyl-D-aspartate (NMDA) receptors in noncompetitive NMDA receptor antagonist-induced hyperlocomotion in mice.
Irifune M; Shimizu T; Nomoto M; Fukuda T
Pharmacol Biochem Behav; 1995; 51(2-3):291-6. PubMed ID: 7667342
[TBL] [Abstract][Full Text] [Related]
24. Systemic administration of MK-801 produces an abnormally persistent latent inhibition which is reversed by clozapine but not haloperidol.
Gaisler-Salomon I; Weiner I
Psychopharmacology (Berl); 2003 Apr; 166(4):333-42. PubMed ID: 12599023
[TBL] [Abstract][Full Text] [Related]
25. Electrophysiological effects of MK-801 on rat nigrostriatal and mesoaccumbal dopaminergic neurons.
Zhang J; Chiodo LA; Freeman AS
Brain Res; 1992 Sep; 590(1-2):153-63. PubMed ID: 1422830
[TBL] [Abstract][Full Text] [Related]
26. Lowered brain stimulation reward thresholds in rats treated with a combination of caffeine and N-methyl-D-aspartate but not alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate or metabotropic glutamate receptor-5 receptor antagonists.
Bespalov A; Dravolina O; Belozertseva I; Adamcio B; Zvartau E
Behav Pharmacol; 2006 Jun; 17(4):295-302. PubMed ID: 16914947
[TBL] [Abstract][Full Text] [Related]
27. Dopaminergic basis for the facilitation of brain stimulation reward by the NMDA receptor antagonist, MK-801.
Olds ME
Eur J Pharmacol; 1996 Jun; 306(1-3):23-32. PubMed ID: 8813611
[TBL] [Abstract][Full Text] [Related]
28. Effect of antipsychotic drugs on brain-derived neurotrophic factor expression under reduced N-methyl-D-aspartate receptor activity.
Fumagalli F; Molteni R; Roceri M; Bedogni F; Santero R; Fossati C; Gennarelli M; Racagni G; Riva MA
J Neurosci Res; 2003 Jun; 72(5):622-8. PubMed ID: 12749027
[TBL] [Abstract][Full Text] [Related]
29. Diet and chronic haloperidol effects on rat midbrain dopamine neurons.
Hamilton ME; Freeman AS
Synapse; 2004 Jul; 53(1):1-5. PubMed ID: 15150734
[TBL] [Abstract][Full Text] [Related]
30. Blockade of MK-801-induced heat shock protein 72/73 in rat brain by antipsychotic and monoaminergic agents targeting D2, 5-HT1A, 5-HT2A and α1-adrenergic receptors.
Romón T; Planas AM; Adell A
CNS Neurol Disord Drug Targets; 2014 Feb; 13(1):104-11. PubMed ID: 24040788
[TBL] [Abstract][Full Text] [Related]
31. Effect of the acute and chronic administration of the putative atypical antipsychotic drug Y-931 (8-fluoro-12- (4-methylpiperazin-1-yl)-6H-[1]benzothieno[2,3b][1,5] benzodiazepine maleate) on spontaneously active rat midbrain dopamine neurons: an in vivo electrophysiological study.
Minabe Y; Hashimoto K; Shirayama Y; Ashby CR
Synapse; 2004 Jan; 51(1):19-26. PubMed ID: 14579422
[TBL] [Abstract][Full Text] [Related]
32. Clozapine, but not haloperidol, prevents the functional hyperactivity of N-methyl-D-aspartate receptors in rat cortical neurons induced by subchronic administration of phencyclidine.
Arvanov VL; Wang RY
J Pharmacol Exp Ther; 1999 May; 289(2):1000-6. PubMed ID: 10215680
[TBL] [Abstract][Full Text] [Related]
33. Bifeprunox and aripiprazole suppress in vivo VTA dopaminergic neuronal activity via D2 and not D3 dopamine autoreceptor activation.
Etievant A; Bétry C; Arnt J; Haddjeri N
Neurosci Lett; 2009 Aug; 460(1):82-6. PubMed ID: 19450663
[TBL] [Abstract][Full Text] [Related]
34. Inhibitory action of clozapine on rat ventral tegmental area dopamine neurons following increased levels of endogenous kynurenic acid.
Schwieler L; Erhardt S
Neuropsychopharmacology; 2003 Oct; 28(10):1770-7. PubMed ID: 12865892
[TBL] [Abstract][Full Text] [Related]
35. Suppressive effect of clozapine but not haloperidol on the increases of neuropeptide-degrading enzymes and glial cells in MK-801-treated rat brain regions.
Arif M; Chikuma T; Ahmed MM; Yoshida S; Kato T
Neurosci Res; 2007 Feb; 57(2):248-58. PubMed ID: 17141345
[TBL] [Abstract][Full Text] [Related]
36. Role of NMDA receptor subtypes in the induction of catalepsy and increase in Fos protein expression after administration of haloperidol.
Yanahashi S; Hashimoto K; Hattori K; Yuasa S; Iyo M
Brain Res; 2004 Jun; 1011(1):84-93. PubMed ID: 15140647
[TBL] [Abstract][Full Text] [Related]
37. Dopamine D2-like antagonists induce chromatin remodeling in striatal neurons through cyclic AMP-protein kinase A and NMDA receptor signaling.
Li J; Guo Y; Schroeder FA; Youngs RM; Schmidt TW; Ferris C; Konradi C; Akbarian S
J Neurochem; 2004 Sep; 90(5):1117-31. PubMed ID: 15312167
[TBL] [Abstract][Full Text] [Related]
38. D-Serine and a glycine transporter-1 inhibitor enhance social memory in rats.
Shimazaki T; Kaku A; Chaki S
Psychopharmacology (Berl); 2010 Apr; 209(3):263-70. PubMed ID: 20198471
[TBL] [Abstract][Full Text] [Related]
39. Acute treatment with the N-methyl-D-aspartate receptor antagonist MK-801: effect of concurrent administration of haloperidol or scopolamine on preproenkephalin mRNA levels of the striatum and nucleus accumbens of the rat brain.
Noailles PA; Villegas M; Ledoux M; Lucas LR; McEwen BS; Angulo JA
Neurosci Lett; 1996 Jan; 202(3):165-68. PubMed ID: 8848257
[TBL] [Abstract][Full Text] [Related]
40. Chronic oral olanzapine treatment but not haloperidol decreases [
Waldman L; Richardson B; Hamilton J; Thanos P
Neurosci Lett; 2022 Jun; 781():136657. PubMed ID: 35483503
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
